Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma [2]

European Journal of Surgical Oncology

Volumn 31, Issue 2, 2005, Pages 211-212

  Molenkamp, B G ^b   Statius Muller, M G ^b   Vuylsteke, R J C L M ^b   van der Sijp, J R M ^b   Meijier, S ^b   van Leeuwen, P A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HUMAN; LETTER; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MELANOMA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 13444251586     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.09.015     Document Type: Letter

References (15)

1. JM Thomas MA Clark Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma Eur J Surg Oncol 30 6 2004 686-691
2. U Veronesi N Cascinelli J Adamus et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm N Engl J Med 318 18 1988 1159-1162
3. N Cascinelli Margin of resection in the management of primary melanoma Semin Surg Oncol 14 4 1998 272-275
4. G Cohn-Cedermark LE Rutqvist R Andersson et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm Cancer 89 7 2000 1495-1501
5. JM Thomas J Newton-Bishop R A'hern et al. Excision margins in high-risk malignant melanoma N Engl J Med 350 8 2004 757-766
6. SH Estourgie OE Nieweg RA Valdes Olmos CA Hoefnagel BB Kroon Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years Ann Surg Oncol 10 6 2003 681-686
7. R Essner A Conforti MC Kelley et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma Ann Surg Oncol 6 5 1999 442-449
8. BM Clary MS Brady JJ Lewis DG Coit Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence Ann Surg 233 2 2001 250-258
9. MG Statius Muller PA van Leeuwen PJ van Diest et al. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients World J Surg 26 12 2002 1405-1411
10. JE Gershenwald MI Colome JE Lee et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma J Clin Oncol 16 6 1998 2253-2260
11. MA Gadd AB Cosimi J Yu et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes Arch Surg 134 4 1999 381-387
12. RJCLM Vuylsteke PAM van Leeuwen MG Statius Muller HA Gietema DR Kragt S Meijer Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: Long-term follow-up results J Clin Oncol 21 6 2003 1057-1065
13. M.M. Urist C.M. Balch S. Soong H.M. Shaw G.W. Milton W.A. Maddox The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma Cancer 55 6 1985 1398-1402
14. C.P. Karakousis D.F. Temple R. Moore J.L. Ambrus Prognostic parameters in recurrent malignant melanoma Cancer 52 3 1983 575-579
15. D.S. Reintgen R. Vollmer C.Y. Tso H.F. Seigler Prognosis for recurrent stage I malignant melanoma Arch Surg 122 11 1987 1338-1342